Arcturus Therapeutics (ARCT) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of$1.69. This compares to earnings of $4.33 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 81.07$1.79 per share when it actually produced a loss of $0.61, delivering a surprise of 65.92%. Over the last four quarter ...